Reported Coronavirus Cases Top 5 Million Worldwide

Here’s what you need to know: ImageA family, wearing protective equipment at a Srinagar graveyard in the Kashmir Valley on Thursday, offered prayers for a woman who died of Covid-19.Credit…Tauseef Mustafa/Agence France-Presse — Getty Images A million new infections were confirmed in less than two weeks. More than five million people worldwide have contracted the coronavirus,…

‘Jaw-Dropping’ Fraud Reported as Jobless Claims Reach 38.6 Million

Here’s what you need to know: ImageVolunteers with the Los Angeles Unified School District provided meals to families in their community at a drive-by grab-and-go on Monday.Credit…Ryan Young for The New York Times A fraud network siphoned hundreds of millions of dollars in unemployment funds. A sophisticated fraud network targeting Washington State’s unemployment system claimed…

No improvement in death rate for COVID-19 patients who received hydroxychloroquine

Boston, MA — A research team led by investigators from Brigham and Women’s Hospital has evaluated real-world evidence related to outcomes for COVID-19 patients who were treated with hydroxychloroquine or chloroquine analogues (with or without a macrolide). Investigators found no evidence that either drug regimen reduced the death rate among patients. Patients treated with hydroxychloroquine…

£7 million government investment in Patient Recruitment Centres for commercial clinical research

NHS patients will benefit from easier access to clinical research opportunities, following a £7 million government investment to launch five new regional Patient Recruitment Centres (PRCs) across England. The five new centres are distributed across the country to provide opportunities for patients in regions across England who may not previously have been able to take…

No evidence blanket ‘do-not-resuscitate’ orders for COVID-19 patients are necessary

DALLAS, May 22, 2020 — It’s inappropriate to consider blanket do-not-resuscitate orders for COVID-19 patients because adequate data is not yet available on U.S. survival rates for in-hospital resuscitation of COVID-19 patients and data from China may not relate to U.S. patients, according to a new article published today in Circulation: Cardiovascular Quality and Outcomes,…

The Lancet: No evidence of benefit for chloroquine and hydroxychloroquine in COVID-19 patients

A large observational study suggests that treatment with the antimalarial drug chloroquine or its analogue hydroxychloroquine (taken with or without the antibiotics azithromycin or clarithromycin) offers no benefit for patients with COVID-19. The study analysed data from nearly 15,000 patients with COVID-19 receiving a combination of any of the four drug regimens and 81,000 controls.…